All articles by Aidan McNamee

Aidan McNamee

Aidan joined Pharmaceutical Technology as a trainee reporter in 2023. With a background in data journalism, he has worked in consumer media covering a wide range of topics, and has a particular interest in big data, AI and the metaverse. Previously, Aidan worked with the Reach Data Unit as part of the Google News Initiative fellowship, and graduated with an MSc in Computational and Data Journalism from Cardiff University in 2022.

AstraZeneca’s STRIDE shows improved outcomes for liver cancer patients

Lower death rates meet higher prices in AstraZeneca’s effective hepatocellular carcinoma therapy.

Pfizer’s Ngenla finally secures FDA approval following a rocky road to market

The FDA issued a complete response letter for Ngenla last year, despite approval being granted in other markets.

Pfizer takes on haemophilia B gene therapy market with new FDA application

Fidanacogene elaparvovec could be a strong contender against CSL’s Hemgenix gene therapy.

FDA approves Biostar’s Phase II/III plans with utidelone injectable for NSCLC

The company hopes to work with other partners to bring Utidelone to market.